NASDAQ:ALDR Alder Biopharmaceuticals (ALDR) Stock Price, News & Analysis → Did You Get Your Free Bitcoin Yet? (From Crypto Swap Profits) (Ad) Free ALDR Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$18.88▼$18.8850-Day Range$18.88▼$18.8852-Week Range$8.39▼$19.12VolumeN/AAverage Volume5.12 million shsMarket Capitalization$1.58 billionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Alder Biopharmaceuticals alerts: Email Address Ad Crypto 101 MediaMajor Elon Musk Crypto Leak RevealedReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy. About Alder Biopharmaceuticals Stock (NASDAQ:ALDR)Alder BioPharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. It discovers, develops, and commercializes therapeutic antibodies to transform the treatment paradigm for patients with migraine in the United States, Australia, and Ireland. The company's lead product candidate is eptinezumab, a monoclonal antibody (mAb) inhibiting calcitonin gene-related peptide, which is in the late-stage clinical development for the prevention of migraine. It also develops ALD1910, a preclinical mAb that inhibits pituitary adenylate cyclase-activating polypeptide-38 for migraine prevention; and Clazakizumab, a mAb inhibiting the pro-inflammatory cytokine interleukin-6 that has completed two Phase 2b clinical trials. The company has strategic collaboration with CSL Limited for the development of clazakizumab as a therapeutic option for solid organ transplant rejection. Alder BioPharmaceuticals, Inc. was incorporated in 2002 and is headquartered in Bothell, Washington.Read More Ad Crypto 101 MediaCrypto Market Preps For Trillions Worth of Inflows! Bitcoin is rapidly approaching new ALL-TIME HIGHS… The market is buzzing after recent approval of spot Bitcoin exchange-traded funds (ETF). Top analysts predict these ETFs will attract trillions of dollars worth of inflows over the next few years… And as Bitcoin rallies, we could see other smaller coins rise to heights never seen before.Click to join the Crypto Community Summit Free Online Event ALDR Stock News HeadlinesMarch 21, 2024 | msn.comObama Drive? Alder proposes renaming prominent Chicago street for former presidentMarch 18, 2024 | msn.comTributes paid to lifelong Swindon Town supporter Ann AlderMarch 29, 2024 | Crypto 101 Media (Ad)SHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. March 14, 2024 | msn.comRishi Sunak's NHS pledge one year on: Waiting lists up at Alder Hey Children's HospitalMarch 12, 2024 | msn.comMore women than men working as doctors at Alder Hey Children's Hospital – bucking trend across NHSMarch 9, 2024 | msn.comHartley, Jonathan Alder win OHSAA Division II boys basketball district championshipsFebruary 19, 2024 | msn.comSchoolboy flown to Alder Hey in serious condition after mountain fallFebruary 9, 2024 | msn.comAlder Hey Children's Trust cares for eight patients with Covid-19 in hospitalMarch 29, 2024 | DTI (Ad)the most reliable asset on earth is making a comebackGlobal tensions have been pushing the price of gold to all time highs… Just recently, gold peaked at a record $2,000 (and is now closer to $2,200). And there’s something else critical at play right now in the world’s largest asset. Because of these critical factors, a lot of massive investment institutions are now pumping more money into gold. And as we speak, some are even calling for a massive rally in the precious metal.February 1, 2024 | tmcnet.comNew Platform Upgrade: Cincoze Showcases the Latest Alder Lake Industrial Computer and a Wide Range of Panel PCsJanuary 31, 2024 | news.yahoo.comAlder Springs ‘Blessings Box’ offers food to those in needJanuary 15, 2024 | msn.comMultiple flu patients at Alder Hey Children's HospitalJanuary 11, 2024 | msn.comMore than four in five A&E arrivals at Alder Hey Children's Hospital seen within four hours – meeting NHS targetJanuary 3, 2024 | finance.yahoo.comDLA Piper Advises Alder Technology in Its Business Combination With Acclaim Technical ServicesDecember 20, 2023 | msn.com'Special day' - Liverpool squad spread Christmas joy with Alder Hey visitDecember 15, 2023 | msn.comFour in five A&E arrivals at Alder Hey Children's Hospital seen within four hours – meeting NHS targetDecember 14, 2023 | msn.comAlcedo's Christmas toy appeal for Alder Hey arrives in WirralDecember 14, 2023 | businesswire.comCincoze Alder Lake-based IPCs Meet the Needs of Various Industrial ApplicationsDecember 13, 2023 | msn.com'A special day for us' - 10 heart-warming pictures as Seamus Coleman joins Everton team at Alder HeyDecember 7, 2023 | msn.comCommunity clashes with Alder Hey chiefs as wait for park drags onDecember 6, 2023 | msn.comGenerous schoolgirl marks five years donating Christmas presents to Alder HeyDecember 1, 2023 | msn.comA third of staff absences in Alder Hey Children's Hospital are stress-relatedNovember 29, 2023 | msn.comWirral mum turns house into ‘Christmas wonderland’ in aid of Alder HeyNovember 20, 2023 | msn.comState of the art cinema coming to Alder Hey Children’s HospitalNovember 17, 2023 | msn.com19 photos capture life at the old Alder Hey Children's HospitalNovember 15, 2023 | msn.comState of the art cinema to give Alder Hey patients 'magical experience'October 24, 2023 | msn.comMadison Alder Vidaver announces run for Dane Co. Executive seatSee More Headlines Receive ALDR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Alder Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/07/2018Today3/29/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical Preparations Sub-IndustryN/A Current SymbolNASDAQ:ALDR CUSIPN/A CIK1423824 Webwww.alderbio.com Phone425-205-2900FaxN/AEmployees202Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($4.87) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-296,430,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-226.13% Return on Assets-66.86% Debt Debt-to-Equity Ratio1.74 Current Ratio8.94 Quick Ratio8.94 Sales & Book Value Annual Sales$1.62 million Price / Sales977.10 Cash FlowN/A Price / Cash FlowN/A Book Value$1.61 per share Price / Book11.73Miscellaneous Outstanding Shares83,840,000Free FloatN/AMarket Cap$1.58 billion OptionableOptionable Beta2.64 Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Key ExecutivesDr. John A. Latham (Age 59)Co-Founder & Chief Scientific Officer Mr. Larry K. Benedict (Age 58)Principal Accounting Officer & Exec. VP Dr. Jeffrey T. L. Smith (Age 59)Managing Director of Alder Biopharmaceuticals Limited Mr. Robert W. Azelby (Age 51)Pres, CEO & Director Mr. Carlos CampoyChief Financial OfficerKey CompetitorsTaro Pharmaceutical IndustriesNYSE:TAROZai LabNASDAQ:ZLABEdgewise TherapeuticsNASDAQ:EWTXDynavax TechnologiesNASDAQ:DVAXMorphicNASDAQ:MORFView All Competitors ALDR Stock Analysis - Frequently Asked Questions How were Alder Biopharmaceuticals' earnings last quarter? Alder Biopharmaceuticals Inc (NASDAQ:ALDR) posted its quarterly earnings results on Tuesday, August, 7th. The biopharmaceutical company reported ($1.04) earnings per share (EPS) for the quarter, topping the consensus estimate of ($1.05) by $0.01. What other stocks do shareholders of Alder Biopharmaceuticals own? Based on aggregate information from My MarketBeat watchlists, some companies that other Alder Biopharmaceuticals investors own include NVIDIA (NVDA), AbbVie (ABBV), (CPXX) (CPXX), Micron Technology (MU), Gilead Sciences (GILD), Alibaba Group (BABA), Synergy Pharmaceuticals (SGYP), Sarepta Therapeutics (SRPT) and Celldex Therapeutics (CLDX). This page (NASDAQ:ALDR) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceAI Cracks Open Largest Untapped Energy Reserve on EarthBanyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryAI healthcare stock poised for 36,996% growth?Behind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alder Biopharmaceuticals Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.